knowledge -WSS

knowledge

author：fashion 2025-09-30 17:27:48 - browse：48

Most everything is looking up for Orexo, the company reported on its second quarter earnings call on Tuesday. That is, everything but its digital therapies pipeline.

The Swedish pharmaceutical company, which makes almost all of its money from U.S. sales of its drug for opioid dependence, notched a number of important victories in the quarter: It successfully defended its patents in a case against Sun Pharmaceuticals, it resolved a packaging issue that was holding up the approval of its long-acting rescue medication, and it grew revenues for Zubsolv, its most important product. The company trimmed its losses to 12.6 million SEK, or $1.2 million, and executives reported that with fewer one-time expenses on the horizon, profitability was “in sight.”

“We are at an exciting turning point for the company and I hope our self confidence and optimism is something that you can share,” CEO Nikolaj Sørensen said on the company’s earnings call while cautioning that “there’s a lot more work to be done.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Wearables generate powerful data but its not useful to doctors, yet

Wikipedia

WSS

NVIDIA and Google execs on the future of AI and drug discovery

Venture capitalist Bob Kocher on the state of digital health

Arc Institute generative AI designs new CRISPR systems

Readout LOUD podcast: Live from STAT Breakthrough Summit West

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

With measles on the rise, a personal story of a devastating disease

explore

knowledge

explore

After affirmative action ruling, medical educators look to 'holistic review'

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

It's time to retire 'poor historian' from clinicians' vocabularies

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

Peter Hotez and the public health issue of online harassment

Case highlights the risks of experimental stem cell therapy

Peter Hotez and the public health issue of online harassment

HIV vaccine remains elusive. Immunologists keep trying new ideas

focus

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

HIV vaccine remains elusive. Immunologists keep trying new ideas

Cytokinetics CEO stresses company can launch heart drug on its own

Military medical care influenced by rank and race, new study finds

Solving academic medical centers' existential crisis

Military medical care influenced by rank and race, new study finds

explore

Wikipedia

Wikipedia

focus